- Sparks Glencoe, Maryland, United States
Commence's unique immunotherapies represent new ways to treat cancers and inflammatory diseases. Based upon the use of certain cells well known for regulating the immune system ("MSCs"), Commence applies its "Stimulated Toll-like Receptor Technology" [STaRT] to program the cells to fight tumors and neurological diseases, amongst others.
Nginx
OpenSSL
Google AdSense
Mobile Friendly